Warning on risks: Financial contracts for difference are complex instruments and are associated with a high risk of rapid financial losses due to leverage. On 77.44% of retail investor accounts, financial losses occur when trading financial contracts for difference with this provider. You should consider whether you understand how financial contracts for difference work, and whether you can afford to take the high risk of suffering financial losses. Please read the Risk Disclosures.
Instruments
22/9/2026
ASML has seen a series of announcements that significantly bolster expectations for further growth. SK hynix announced the purchase of its technologies for nearly $8 billion, management raised its annual revenue outlook to as much as €45 billion, and September announcements from TSMC, Samsung, and Intel bolstered the future of the latest generation of lithography systems. At the same time, analysts’ average price target stands at 2,023.94 EUR. [1]
14/9/2026
United Natural Foods closed fiscal year 2026 in a way that could significantly influence investors’ outlook on the company’s future development. Behind the latest quarterly figures lies a significant turnaround in the company’s performance and a sign that the food distributor is entering a new phase. The market is now waiting to see whether this marks the beginning of a steady improvement or is merely a short-term fluctuation. [1]
7/9/2026
Medtronic kicked off fiscal year 2027 with results that caught investors’ attention and suggested that something significant may be unfolding in the healthcare sector. The company also revised its full-year outlook, but the true picture of its performance will only become clear once the details of individual segments and the impact of calendar factors are revealed. [1]Do you have any questions?
We will be happy to help you.
Our support team is ready to help you. Call or write - we are here for you.